As of May 31, 2025, MEI Pharma Inc (MEIP) reports a EV/EBITDA of 0.26.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing MEI Pharma Inc's EV/EBITDA to Peers
To better understand MEI Pharma Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| MEI Pharma Inc (MEIP) | 0.26 |
| ADMA Biologics Inc (ADMA) | 29.40 |
| Abbvie Inc (ABBV) | 17.71 |
| Theratechnologies Inc (TH.TO) | 15.35 |
| Amgen Inc (AMGN) | 14.74 |
| Regeneron Pharmaceuticals Inc (REGN) | 14.60 |
Compared to its competitors, MEI Pharma Inc's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.